Olmesartan-HCT-Mepha Teva 20/12.5 mg
Olmesartan-HCT-Mepha Teva 20/12.5 mg is a medicine authorised by Swissmedic under authorisation number 68456. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 April 2022 and the authorisation is valid without a time limit. ATC code C09DA08 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 68456 |
|---|---|
| Name | Olmesartan-HCT-Mepha Teva 20/12.5 mg |
| Full name | Olmesartan-HCT-Mepha Teva 20/12.5 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DA08 |
| First authorisation | 28 April 2022 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Olmesartan-HCT-Mepha Teva 20/12.5 mg, Filmtabletten | B | 28 April 2022 |
| 2 | Olmesartan-HCT-Mepha Teva 20/25 mg, Filmtabletten | B | 28 April 2022 |
| 3 | Olmesartan-HCT-Mepha Teva 40/12.5 mg, Filmtabletten | B | 28 April 2022 |
| 4 | Olmesartan-HCT-Mepha Teva 40/25 mg, Filmtabletten | B | 28 April 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | C09DA08 | 02.07.2. | B |
| 2 | 98 | Tablette(n) | C09DA08 | 02.07.2. | B |
| 3 | 28 | Tablette(n) | C09DA08 | 02.07.2. | B |
| 4 | 98 | Tablette(n) | C09DA08 | 02.07.2. | B |
| 5 | 28 | Tablette(n) | C09DA08 | 02.07.2. | B |
| 6 | 98 | Tablette(n) | C09DA08 | 02.07.2. | B |
| 7 | 28 | Tablette(n) | C09DA08 | 02.07.2. | B |
| 8 | 98 | Tablette(n) | C09DA08 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Olmesartan-HCT-Mepha Teva 20/12.5 mg authorised in Switzerland?
Yes. Olmesartan-HCT-Mepha Teva 20/12.5 mg is authorised by Swissmedic under authorisation number 68456, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Olmesartan-HCT-Mepha Teva 20/12.5 mg have?
Olmesartan-HCT-Mepha Teva 20/12.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Olmesartan-HCT-Mepha Teva 20/12.5 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.